GW Pharmaceuticals turns over $108M in Q4 sales thanks to CBD-based medicine
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• January 27, 2020
CEO of GW Pharma talks about Epidiolex getting FDA approval
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• July 2, 2018
Will Epidiolex be the first cannabis-based drug to be approved as an epilepsy treatment?
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• May 3, 2018
Load More Stories